ENCell Co., Ltd. (KOSDAQ:456070)

Market Cap	168.00B
Revenue	n/a
Net Income	n/a
Shares Out	10.77M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	390,017
Average Volume	944,174
Open	16,320
Previous Close	16,270
Day's Range	15,220 - 16,900
52-Week Range	12,100 - 45,800
Beta	n/a
RSI	36.22
Earnings Date	n/a

About ENCell

ENCell Co., Ltd. develops cell/gene-based biopharmaceutical products in South Korea. The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease It also provides contracting development and manufacturing services for biopharmaceutical products. The company was founded in 2018 and is based in Seoul, South Korea.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 456070